ARKAY Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients (NCT03686657) | ARKAY Therapeutics | 2026-12-10 |
Track ARKAY Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.